Cargando…

Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma

PURPOSE: The current study aimed to construct a novel cancer artificial intelligence survival analysis system for predicting the individual mortality risk curves for cervical carcinoma patients receiving different treatments. METHODS: Study dataset (n = 14,946) was downloaded from Surveillance Epide...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jieyi, He, Tingshan, Li, Hong, Guo, Xueqing, Zhang, Zhiqiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238034/
https://www.ncbi.nlm.nih.gov/pubmed/35765031
http://dx.doi.org/10.1186/s12967-022-03491-8
_version_ 1784736937022586880
author Liang, Jieyi
He, Tingshan
Li, Hong
Guo, Xueqing
Zhang, Zhiqiao
author_facet Liang, Jieyi
He, Tingshan
Li, Hong
Guo, Xueqing
Zhang, Zhiqiao
author_sort Liang, Jieyi
collection PubMed
description PURPOSE: The current study aimed to construct a novel cancer artificial intelligence survival analysis system for predicting the individual mortality risk curves for cervical carcinoma patients receiving different treatments. METHODS: Study dataset (n = 14,946) was downloaded from Surveillance Epidemiology and End Results database. Accelerated failure time algorithm, multi-task logistic regression algorithm, and Cox proportional hazard regression algorithm were used to develop prognostic models for cancer specific survival of cervical carcinoma patients. RESULTS: Multivariate Cox regression identified stage, PM, chemotherapy, Age, PT, and radiation_surgery as independent influence factors for cervical carcinoma patients. The concordance indexes of Cox model were 0.860, 0.849, and 0.848 for 12-month, 36-month, and 60-month in model dataset, whereas it were 0.881, 0.845, and 0.841 in validation dataset. The concordance indexes of accelerated failure time model were 0.861, 0.852, and 0.851 for 12-month, 36-month, and 60-month in model dataset, whereas it were 0.882, 0.847, and 0.846 in validation dataset. The concordance indexes of multi-task logistic regression model were 0.860, 0.863, and 0.861 for 12-month, 36-month, and 60-month in model dataset, whereas it were 0.880, 0.860, and 0.861 in validation dataset. Brier score indicated that these three prognostic models have good diagnostic accuracy for cervical carcinoma patients. The current research lacked independent external validation study. CONCLUSION: The current study developed a novel cancer artificial intelligence survival analysis system to provide individual mortality risk predictive curves for cervical carcinoma patients based on three different artificial intelligence algorithms. Cancer artificial intelligence survival analysis system could provide mortality percentage at specific time points and explore the actual treatment benefits under different treatments in four stages, which could help patient determine the best individualized treatment. Cancer artificial intelligence survival analysis system was available at: https://zhangzhiqiao15.shinyapps.io/Tumor_Artificial_Intelligence_Survival_Analysis_System/. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03491-8.
format Online
Article
Text
id pubmed-9238034
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92380342022-06-29 Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma Liang, Jieyi He, Tingshan Li, Hong Guo, Xueqing Zhang, Zhiqiao J Transl Med Research PURPOSE: The current study aimed to construct a novel cancer artificial intelligence survival analysis system for predicting the individual mortality risk curves for cervical carcinoma patients receiving different treatments. METHODS: Study dataset (n = 14,946) was downloaded from Surveillance Epidemiology and End Results database. Accelerated failure time algorithm, multi-task logistic regression algorithm, and Cox proportional hazard regression algorithm were used to develop prognostic models for cancer specific survival of cervical carcinoma patients. RESULTS: Multivariate Cox regression identified stage, PM, chemotherapy, Age, PT, and radiation_surgery as independent influence factors for cervical carcinoma patients. The concordance indexes of Cox model were 0.860, 0.849, and 0.848 for 12-month, 36-month, and 60-month in model dataset, whereas it were 0.881, 0.845, and 0.841 in validation dataset. The concordance indexes of accelerated failure time model were 0.861, 0.852, and 0.851 for 12-month, 36-month, and 60-month in model dataset, whereas it were 0.882, 0.847, and 0.846 in validation dataset. The concordance indexes of multi-task logistic regression model were 0.860, 0.863, and 0.861 for 12-month, 36-month, and 60-month in model dataset, whereas it were 0.880, 0.860, and 0.861 in validation dataset. Brier score indicated that these three prognostic models have good diagnostic accuracy for cervical carcinoma patients. The current research lacked independent external validation study. CONCLUSION: The current study developed a novel cancer artificial intelligence survival analysis system to provide individual mortality risk predictive curves for cervical carcinoma patients based on three different artificial intelligence algorithms. Cancer artificial intelligence survival analysis system could provide mortality percentage at specific time points and explore the actual treatment benefits under different treatments in four stages, which could help patient determine the best individualized treatment. Cancer artificial intelligence survival analysis system was available at: https://zhangzhiqiao15.shinyapps.io/Tumor_Artificial_Intelligence_Survival_Analysis_System/. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03491-8. BioMed Central 2022-06-28 /pmc/articles/PMC9238034/ /pubmed/35765031 http://dx.doi.org/10.1186/s12967-022-03491-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liang, Jieyi
He, Tingshan
Li, Hong
Guo, Xueqing
Zhang, Zhiqiao
Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma
title Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma
title_full Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma
title_fullStr Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma
title_full_unstemmed Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma
title_short Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma
title_sort improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238034/
https://www.ncbi.nlm.nih.gov/pubmed/35765031
http://dx.doi.org/10.1186/s12967-022-03491-8
work_keys_str_mv AT liangjieyi improveindividualtreatmentbycomparingtreatmentbenefitscancerartificialintelligencesurvivalanalysissystemforcervicalcarcinoma
AT hetingshan improveindividualtreatmentbycomparingtreatmentbenefitscancerartificialintelligencesurvivalanalysissystemforcervicalcarcinoma
AT lihong improveindividualtreatmentbycomparingtreatmentbenefitscancerartificialintelligencesurvivalanalysissystemforcervicalcarcinoma
AT guoxueqing improveindividualtreatmentbycomparingtreatmentbenefitscancerartificialintelligencesurvivalanalysissystemforcervicalcarcinoma
AT zhangzhiqiao improveindividualtreatmentbycomparingtreatmentbenefitscancerartificialintelligencesurvivalanalysissystemforcervicalcarcinoma